Scott Jeffers
Hoofd Techniek/Wetenschap/O&O bij GENSIGHT BIOLOGICS S.A.
Actieve functies van Scott Jeffers
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GENSIGHT BIOLOGICS S.A. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 | - |
Loopbaan van Scott Jeffers
Eerdere bekende functies van Scott Jeffers
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Opleiding van Scott Jeffers
Purdue University | Doctorate Degree |
Colorado State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Redpin Therapeutics, Inc.
Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Commercial Services |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Beurs
- Insiders
- Scott Jeffers
- Ervaring